First-hand Strategic Insights & Actionable Takeaways
A significant investment in the development of continuous manufacturing (CM) processes for small molecule drug products has occurred over the last ten years in the pharmaceutical industry. Throughout this period, companies have achieved global regulatory approvals for multiple products and gained invaluable technical and regulatory experiences that will help them further advance their continuous manufacturing platforms. As the industry begins the second decade of investment in continuous manufacturing processes, it is worth taking a moment to reflect on some of the successes and challenges of the first ten years and leverage those experiences to set the vision for the future. This ISPE Expert XChange will highlight how some of the early adopters and practitioners of continuous manufacturing are evolving their capabilities and strategies for the future to fully exploit all of the advantages that continuous manufacturing platforms have to offer.
During this highly interactive session, you will get the opportunity to engage with the Subject Matter Experts through:
Don’t miss out on this next-generation virtual experience – ISPE Expert Xchange!
*ISPE Membership is required for these rates.
Bring your team to the ISPE Expert Xchange: Next Decade of Continuous Manufacturing
Group discount applies to Member/Nonmember rate only. To qualify, all registrant information must be submitted at the same time. Registrations that arrive later will NOT be eligible for the group discount. Cannot be combined with other offers. To register as a group, please contact ISPE by telephone, +1-813-960-2105 or by email, ask@ispe.org.
Become a member today
Gain the knowledge and competitive edge you need to succeed in the pharmaceutical and biopharmaceutical engineering industries and join more than 18,000 pharma professionals from around the world by becoming an ISPE Member.
Benefits include: